Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray

Lina Yang(Qingdao University), Sheng‐ce Tao(Shanghai Jiao Tong University), Jingfang Wang(Shanxi Medical University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Qi Chong(Fudan University), Bin Lan(Fujian Medical University), Min Yan(Zhengzhou University), Jianfang Li(Shanghai Jiao Tong University), Bingya Liu(Shanghai Jiao Tong University), Wei Li(Shanghai Tenth People's Hospital), Zhifeng Shao(Shanghai Jiao Tong University), Youcheng Ding(Shanghai East Hospital), Hainan Zhang(Shanghai Jiao Tong University), Heng Zhu(Chinese Academy of Sciences), Xiaonian Gu(Second Military Medical University), Shujuan Guo(Shanghai Jiao Tong University), Ming Xu(Yanshan University)
Molecular & Cellular Proteomics
November 23, 2015
10.1074/mcp.m115.051250
Cited by 96

Related Papers

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
|Science China Life Sciences|2020|2.3k
Global Analysis of Protein Activities Using Proteome Chips
|Science|2001|1.9k
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|Cell|2016|1.1k
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
|Cell|2019|858
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743